Serum levels of LIGHT in MS (Q57224216)

Clas Malmeström

1

0 references

Jan Lycke

Jan Lycke

12

0 references

Bob Olsson

Bob Olsson

14

0 references

Mohsen Khademi

Mohsen Khademi

4

0 references

Ingrid Kockum

Ingrid Kockum

6

0 references

Henrik Zetterberg

8

Henrik Zetterberg

0 references

Kaj Blennow

9

Kaj Blennow

0 references

Niklas Mattsson

7

Niklas Mattsson

0 references

Tomas Olsson

13

Tomas Olsson

0 references

author name string

Alan Gillett

2

0 references

Margareta Jernås

3

0 references

Markus Axelsson

5

0 references

Hans Wadenvik

Multiple Sclerosis Journal

11

0 references

publication date

4 October 2012

0 references

published in

0 references

volume

19

0 references

issue

7

0 references

page(s)

871-876

0 references

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Unconventional ligand activation of herpesvirus entry mediator signals cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463766